Medtronic earns CE Mark for direct aortic implantation of CoreValve

11/9/2011 | Clinica (subscription required)

European regulators have granted Medtronic approval for the delivery of its CoreValve transcatheter aortic valve implant using a direct aortic approach. The new delivery approach offers an alternative for patients who are not fit to receive the device through femoral artery implantation, said Kathleen Janasz at Medtronic.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA